Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1981 Mar;72(3):411–417. doi: 10.1111/j.1476-5381.1981.tb10991.x

Effect of intracisternal 5,-7-dihydroxytryptamine on the acute antihypertensive action of propranolol in the sino-aortic denervated anaesthetized dog.

J L Montastruc, P Montastruc
PMCID: PMC2071595  PMID: 7260484

Abstract

1 The anti-hypertensive effects of intravenously and intracisternally administered (+/-)-propranolol were studied in anaesthetized dogs with acute neurogenic (sino-aortic denervation) hypertension. The animals were pretreated 7 days earlier with intracisternally administered 5,7-dihydroxytryptamine (5,7-DHT 200 microgram/kg plus desipramine 5 mg/kg i.v.). 2 5,7-DHT (plus desipramine) failed to decrease both basic blood pressure and heart rate measured before sino-aortic denervation. After 5,7-DHT (plus desipramine) pretreatment, acute sino-aortic denervation induced a rise in blood pressure and stimulated the heart rate, these effects being similar (in intensity and duration) to those observed in control (saline-pre-treated) debuffered dogs during the first hour following the deafferentation. 3 In debuffered dogs, (+/-)-propranolol given by intracisternal (50 microgram/kg) or intravenous (300 microgram/kg) routes decreased both blood pressure and heart rate. 4 5,-DHT (plus desipramine) pretreatment abolished the antihypertensive effect of intracisternal propranolol whereas the action of intravenous propranolol was only delayed. In contrast, this pretreatment failed to reduce and even sometimes enhanced the negative chronotropic response induced by propranolol. 5 These results suggest that central 5-hydroxytryptaminergic pathways play an important role in the acute hypotension elicited by intracisternal (+/-)-propranolol in debuffered hypertensive anaesthetized dogs, but little, if any in propranolol-induced bradycardia.

Full text

PDF
411

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baumgarten H. G., Björklund A., Lachenmayer L., Nobin A., Stenevi U. Long-lasting selective depletion of brain serotonin by 5,6-dihydroxytryptamine. Acta Physiol Scand Suppl. 1971;373:1–15. [PubMed] [Google Scholar]
  2. Baumgarten H. G., Evetts K. D., Holman R. B., Iversen L. L., Vogt M., Wilson G. Effects of 5,6-dihydroxytryptamine on monoaminergic neurones in the central nervous system of the rat. J Neurochem. 1972 Jun;19(6):1587–1597. doi: 10.1111/j.1471-4159.1972.tb05102.x. [DOI] [PubMed] [Google Scholar]
  3. Björklund A., Baumgarten H. G., Rensch A. 5,7-Dihydroxytryptamine: improvement of its selectivity for serotonin neurons in the CNS by pretreatment with desipramine. J Neurochem. 1975 Apr;24(4):833–835. [PubMed] [Google Scholar]
  4. Chalmers J. P. Brain amines and models of experimental hypertension. Circ Res. 1975 Apr;36(4):469–480. doi: 10.1161/01.res.36.4.469. [DOI] [PubMed] [Google Scholar]
  5. Daly J., Fuxe K., Jonsson G. Effects of intracerebral injections of 5,6-dihydroxytryptamine on central monoamine neurons: evidence for selective degeneration of central 5-hydroxytryptamine neurons. Brain Res. 1973 Jan 30;49(2):476–482. doi: 10.1016/0006-8993(73)90446-0. [DOI] [PubMed] [Google Scholar]
  6. Direct evidence for an interaction of beta-adrenergic blockers with the 5-HT receptor. Nature. 1977 May 19;267(5608):289–290. doi: 10.1038/267289a0. [DOI] [PubMed] [Google Scholar]
  7. Finch L. The cardiovascular effects of intraventricular 5,6-dihydroxytryptamine in conscious hypertensive rats. Clin Exp Pharmacol Physiol. 1975 Nov-Dec;2(6):503–508. doi: 10.1111/j.1440-1681.1975.tb01855.x. [DOI] [PubMed] [Google Scholar]
  8. Fuxe K., Hökfelt T., Ungerstedt U. Localization of indolealkylamines in CNS. Adv Pharmacol. 1968;6(Pt A):235–251. doi: 10.1016/s1054-3589(08)61177-1. [DOI] [PubMed] [Google Scholar]
  9. Green A. R., Grahame-Smith D. G. (-)-Propranolol inhibits the behavioural responses of rats to increased 5-hydroxytryptamine in the central nervous system. Nature. 1976 Aug 12;262(5569):594–596. doi: 10.1038/262594a0. [DOI] [PubMed] [Google Scholar]
  10. Lambert G. A., Friedman E., Buchweitz E., Gershon S. Involvement of 5-hydroxytryptamine in the central control of respiration, blood pressure and heart rate in the anaesthetized rat. Neuropharmacology. 1978 Oct;17(10):807–813. doi: 10.1016/0028-3908(78)90068-0. [DOI] [PubMed] [Google Scholar]
  11. Lewis P. The essential action of propranolol in hypertension. Am J Med. 1976 May 31;60(6):837–852. doi: 10.1016/0002-9343(76)90904-9. [DOI] [PubMed] [Google Scholar]
  12. Montastruc J. L., Montastruc P. Antihypertensive effects of intra-cisternal beta-blocking agents in dogs with acute nerogenic hypertension. Arch Int Pharmacodyn Ther. 1979 Feb;237(2):275–281. [PubMed] [Google Scholar]
  13. Montastruc J. L., Montastruc P. Effect of intracisternal application of 6-hydroxydopamine on the antihypertensive action of propranolol in the dog. Eur J Pharmacol. 1980 May 2;63(2-3):103–116. doi: 10.1016/0014-2999(80)90434-3. [DOI] [PubMed] [Google Scholar]
  14. Montastruc J. L., Montastruc P. Effect of intracisternal butoxamine, a beta-2 adrenoceptor blocking agent, on blood pressure and heart rate in the dog. Arch Int Pharmacodyn Ther. 1980 Jan;243(1):132–138. [PubMed] [Google Scholar]
  15. Nelson D. L., Herbet A., Bourgoin S., Glowinski J., Hamon M. Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat. Mol Pharmacol. 1978 Nov;14(6):983–995. [PubMed] [Google Scholar]
  16. Schechter Y., Weinstock M. Beta-adrenoceptor blocking agents and responses to adrenaline and 5-hydroxytryptamine in rat isolated stomach and uterus. Br J Pharmacol. 1974 Oct;52(2):283–287. doi: 10.1111/j.1476-5381.1974.tb09711.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Scriabine A. Beta-adrenoceptor blocking drugs in hypertension. Annu Rev Pharmacol Toxicol. 1979;19:269–284. doi: 10.1146/annurev.pa.19.040179.001413. [DOI] [PubMed] [Google Scholar]
  18. Weinstock M., Schechter Y. Antagonism by propranolol of the ganglion stimulant action of 5-hydroxytryptamine. Eur J Pharmacol. 1975 Jun-Jul;32(02):293–301. doi: 10.1016/0014-2999(75)90296-4. [DOI] [PubMed] [Google Scholar]
  19. Weinstock M., Weiss C., Gitter S. Blockade of 5-hydroxytryptamine receptors in the central nervous system by beta-adrenoceptor antagonists. Neuropharmacology. 1977 Apr;16(4):273–276. doi: 10.1016/0028-3908(77)90106-x. [DOI] [PubMed] [Google Scholar]
  20. Wing L. M., Chalmers J. P. Participation of central serotonergic neurons in the control of the circulation of the unanesthetized rabbit. A study using 5,6-dihydroxytryptamine in experimental neurogenic and renal hypertension. Circ Res. 1974 Sep;35(3):504–513. doi: 10.1161/01.res.35.3.504. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES